HEART FAILURE, DIASTOLIC
Clinical trials for HEART FAILURE, DIASTOLIC explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE, DIASTOLIC trials appear
Sign up with your email to follow new studies for HEART FAILURE, DIASTOLIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart failure drug enters early safety testing
Symptom relief Not yet recruitingThis early-stage study tests a single dose of the experimental drug LY3971297 in 90 people with heart failure (either with preserved or reduced pumping ability). The main goal is to check for side effects and how the body handles the drug. Participants will be monitored for about…
Matched conditions: HEART FAILURE, DIASTOLIC
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated May 17, 2026 09:25 UTC
-
Heart failure study aims to uncover hidden patient groups
Knowledge-focused Not yet recruitingThis study looks at 200 adults with a type of heart failure called HFpEF to see if they can be grouped into different categories based on their medical information. Researchers want to know if these groups have different health profiles and respond differently during an exercise …
Matched conditions: HEART FAILURE, DIASTOLIC
Sponsor: Instituto Politécnico de Leiria • Aim: Knowledge-focused
Last updated May 17, 2026 09:21 UTC
-
New study probes Tirzepatide's heart benefits in Obesity-Related heart failure
Knowledge-focused Not yet recruitingThis study looks at how tirzepatide, a diabetes drug, helps people with obesity and a type of heart failure called HFpEF. Researchers will measure blood volume and body fat in 50 patients over 15 months to understand how the drug works. The goal is to find out if tirzepatide redu…
Matched conditions: HEART FAILURE, DIASTOLIC
Phase: PHASE4 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 17, 2026 09:19 UTC